Status:

RECRUITING

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Lead Sponsor:

Pfizer

Conditions:

Atopic Dermatitis

Eczema, Atopic

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this co...

Eligibility Criteria

Inclusion

  • Participants must meet the following criteria:
  • Are 18 years of age or older
  • Have clinical diagnosis of AD for at least 6 months prior to Day 1 and have diagnosis of AD confirmed by photographs
  • Have moderate to severe AD as defined by the following at screening and baseline visits:
  • Affected body surface area (BSA) greater than or equal to 10% and up to 60%;
  • Validated Investigator's Global Assessment (vIGA) greater than or equal to 3;
  • Eczema Area and Severity Index (EASI) greater than or equal to 16;
  • AND
  • Peak Pruritis Numeric Rating Scale (PP-NRS) greater than or equal to 4 at screening and a weekly average of greater than or equal to 4 at baseline visit
  • Do not have a suitable prescribed medicine for AD.
  • Body Mass Index (BMI) of 17.5 to 40 kg/m2 and a total body weight greater than 45 kg (100 lbs)

Exclusion

  • Participants must not meet the following criteria:
  • Have an infection that requires treatment
  • Have other skin conditions other than AD
  • Have severe uncontrolled asthma
  • Regular use (more than 2 visits per week) of a tanning booth or phototherapy for AD within 4 weeks of the screening visit

Key Trial Info

Start Date :

November 20 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 23 2027

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT07216027

Start Date

November 20 2025

End Date

August 23 2027

Last Update

December 5 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Clinical Science Institute

Santa Monica, California, United States, 90404

2

Gsi Clinical Research

Margate, Florida, United States, 33063

3

Skin Research of South Florida

Miami, Florida, United States, 33173

4

Goodlettsville Dermatology Research

Goodlettsville, Tennessee, United States, 37072